Metrics as of 10/17/2026, 07:38 AM (Berlin time), refresh in progress.
The Cooper Companies, Inc.
The Cooper Companies, Inc. is a global healthcare company headquartered in San Ramon, USA. Founded in 1958, the company is listed on the NASDAQ. The business operates as a medical device firm focused on developing, producing, and distributing products through two distinct business units. The segment CooperVision…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
+0.9%
1W
+6.6%
1M
+6.1%
6M
-17.3%
YTD
-29.3%
1Y
-19.0%
2Y
-46.6%
5Y
-41.8%
10Y
+30.5%
Next earnings date
03/12/2026 (in 47 days)
Volatility around earnings
~70% stronger price swings than usual
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Register for free
Unlock all 11 scores
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
PRICE TARGET LOW
US$59.00
CONSENSUS
US$65.11
MEDIAN
US$61.00
PRICE TARGET HIGH
US$75.00
0
STRONG BUY
14
BUY
13
HOLD
1
SELL
0
STRONG SELL
28
TOTAL · Buy
As of: 15/09/2026
P/E
19.77
P/B
1.35
EV/EBITDA
14.73
RETURN ON EQUITY
5.2%
NET MARGIN
40.6%
DEBT/EQUITY
0.31
DIVIDEND YIELD
0.0%
AS OF
31/07/2026
FREE FLOAT
99.4%
FLOAT SHARES
188,943,713
AVG. DAILY VOLUME (30D)
5,059,286
Kurzius Lawrence Erik
Kurzius Lawrence Erik
Rosebrough Walter M Jr
Rosebrough Walter M Jr
Keel Paul A
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.9%
Forums (Reddit)
See the full forum history with Pro.
Register for free
Register now to see which funds are invested
The Cooper Companies, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Albert G. White, the company employs around 15,000 people.
The IPO was on 21/01/1983; the stock trades on NASDAQ under the ticker COO.
28 analysts rate the stock, the consensus is Buy (as of 15/09/2026).
The average price target is US$65.11, ranging from US$59.00 to US$75.00, with a median of US$61.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 03/12/2026.
Around past earnings, price swings were roughly 70% stronger than usual.
Yes. The last dividend was US$0.03 per share, ex-date 26/07/2023, paid on 11/08/2023.
The dividend yield is 0.0% (as of 31/07/2026).
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Avantor and Repligen.
Clicking "Analyze stock" lets five strategies assess Cooper Companies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.